Barlabé, P., Sostoa, J. d., Fajardo Calderón, C. A., Alemany Bonastre, R., & Moreno Olié, R. (2019). Enhanced antitumor efficacy of an oncolytic adenovirus armed with an EGFR-targeted BiTE using menstrual blood-derived mesenchymal stem cells as carriers.
Citación estilo ChicagoBarlabé, Paula, Jana de Sostoa, Carlos Alberto Fajardo Calderón, Ramon Alemany Bonastre, y Rafael Moreno Olié. Enhanced Antitumor Efficacy of an Oncolytic Adenovirus Armed With an EGFR-targeted BiTE Using Menstrual Blood-derived Mesenchymal Stem Cells As Carriers. 2019.
Cita MLABarlabé, Paula, et al. Enhanced Antitumor Efficacy of an Oncolytic Adenovirus Armed With an EGFR-targeted BiTE Using Menstrual Blood-derived Mesenchymal Stem Cells As Carriers. 2019.
Precaución: Estas citas no son 100% exactas.